Brief: Xvivo Perfusion: Lung Bioengineering Buys XVIVO Perfusion System
Aug 23 (Reuters) - Xvivo Perfusion AB XVIVO.ST :
* LUNG BIOENGINEERING HAS ACQUIRED THE XPS™ FOR USE IN ITS
NEW
JACKSONVILLE EVLP CENTER
* LUNG BIOENGINEERING INC., A SUBSIDIARY OF UNITED
THERAPEUTICS
CORPORATION (NASDAQ: UTHR), HAS PURCHASED AN XVIVO PERFUSION
SYSTEM (XPS™)
Source text for Eikon: ID:nWkr2ykx0F
Further company coverage: XVIVO.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Xvivo Perfusion AB
See all newsSweden's XVIVO Q3 revenue beat expectations on thoracic sales
Brief: Xvivo Q3 EBIT SEK 28 Million
Brief: Xvivo Receives CE Certificates For Heart Preservation Technology
Brief: XVIVO Gets FDA Approval For Additional Patient Enrollment
Sweden's XVIVO Q2 sales beat estimates, helped by thoracic segment strength